Lentiviral delivery of combinatorial CAR/CRISPRi circuit into human primary T cells is enhanced by TBK1/IKKɛ complex inhibitor BX795
Lingyu Li(China Agricultural University), Francesco M. Marincola(Refuge Biotechnologies (United States)), Lihong Weng(CTI BioPharma (United Kingdom)), Qinghui Xiong(Hangzhou DAC Biotech (China)), Zhifen Yang(Ministry of Education), Alejandra Pelayo(Refuge Biotechnologies (United States)), Yuan Gao(National Center for Nanoscience and Technology), Rona Harari-Steinfeld(Refuge Biotechnologies (United States)), Carolyn R. Denson(Refuge Biotechnologies (United States)), Wei Wang(Sichuan University), Zhiming Fang(Hangzhou DAC Biotech (China)), Lei S. Qi(Chan Zuckerberg Initiative (United States)), Richa Srivastava(Institute of Management Technology), Angshumala Goswami(Refuge Biotechnologies (United States))
Cited by 35
Related Papers
The JAK/STAT signaling pathway: from bench to clinic
|Signal Transduction and Targeted Therapy|2021|2.4k
A new class of membrane-bound chemokine with a CX3C motif
|Nature|1997|2k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
|Journal for ImmunoTherapy of Cancer|2020|1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803